
Cynthia M. Fogg
Examiner (ID: 15689, Phone: (571)272-2741 , Office: P/2427 )
| Most Active Art Unit | 2421 |
| Art Unit(s) | 2421, 2427 |
| Total Applications | 531 |
| Issued Applications | 391 |
| Pending Applications | 52 |
| Abandoned Applications | 100 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3659512
[patent_doc_number] => 05591771
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-07
[patent_title] => 'Use of propolis components as an adjuvant'
[patent_app_type] => 1
[patent_app_number] => 8/474103
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1901
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/591/05591771.pdf
[firstpage_image] =>[orig_patent_app_number] => 474103
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/474103 | Use of propolis components as an adjuvant | Jun 6, 1995 | Issued |
Array
(
[id] => 3695218
[patent_doc_number] => 05650430
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Radicicol derivatives, their preparation and their anti-tumor activity'
[patent_app_type] => 1
[patent_app_number] => 8/473099
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39277
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650430.pdf
[firstpage_image] =>[orig_patent_app_number] => 473099
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473099 | Radicicol derivatives, their preparation and their anti-tumor activity | Jun 6, 1995 | Issued |
Array
(
[id] => 3622943
[patent_doc_number] => 05614643
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-25
[patent_title] => 'Process for the enzymatic production of isomerically pure isosorbide-2 and 5-monoesters as well as their conversion into isosorbide-2- and 5-nitrate'
[patent_app_type] => 1
[patent_app_number] => 8/481915
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3860
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/614/05614643.pdf
[firstpage_image] =>[orig_patent_app_number] => 481915
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481915 | Process for the enzymatic production of isomerically pure isosorbide-2 and 5-monoesters as well as their conversion into isosorbide-2- and 5-nitrate | Jun 6, 1995 | Issued |
Array
(
[id] => 3718303
[patent_doc_number] => 05616733
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-01
[patent_title] => 'Preparation method for 2-coumaranone'
[patent_app_type] => 1
[patent_app_number] => 8/472400
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2737
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/616/05616733.pdf
[firstpage_image] =>[orig_patent_app_number] => 472400
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472400 | Preparation method for 2-coumaranone | Jun 6, 1995 | Issued |
Array
(
[id] => 3776830
[patent_doc_number] => 05808109
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Compounds that inhibit complement and/or suppress immune activity'
[patent_app_type] => 1
[patent_app_number] => 8/484094
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 25409
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808109.pdf
[firstpage_image] =>[orig_patent_app_number] => 484094
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484094 | Compounds that inhibit complement and/or suppress immune activity | Jun 6, 1995 | Issued |
Array
(
[id] => 3877751
[patent_doc_number] => 05747527
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes'
[patent_app_type] => 1
[patent_app_number] => 8/479049
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10200
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747527.pdf
[firstpage_image] =>[orig_patent_app_number] => 479049
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/479049 | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | Jun 5, 1995 | Issued |
Array
(
[id] => 3683144
[patent_doc_number] => 05633279
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-27
[patent_title] => '5-substituted derivatives of mycophenolic acid'
[patent_app_type] => 1
[patent_app_number] => 8/483042
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44479
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 617
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/633/05633279.pdf
[firstpage_image] =>[orig_patent_app_number] => 483042
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483042 | 5-substituted derivatives of mycophenolic acid | Jun 5, 1995 | Issued |
Array
(
[id] => 3552278
[patent_doc_number] => 05571914
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-05
[patent_title] => '4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof'
[patent_app_type] => 1
[patent_app_number] => 8/466733
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15606
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/571/05571914.pdf
[firstpage_image] =>[orig_patent_app_number] => 466733
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466733 | 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof | Jun 5, 1995 | Issued |
Array
(
[id] => 3494689
[patent_doc_number] => 05536847
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-16
[patent_title] => '4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof'
[patent_app_type] => 1
[patent_app_number] => 8/471524
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15587
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 322
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/536/05536847.pdf
[firstpage_image] =>[orig_patent_app_number] => 471524
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471524 | 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof | Jun 5, 1995 | Issued |
Array
(
[id] => 3666814
[patent_doc_number] => 05599820
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment'
[patent_app_type] => 1
[patent_app_number] => 8/461730
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19559
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599820.pdf
[firstpage_image] =>[orig_patent_app_number] => 461730
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461730 | Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment | Jun 4, 1995 | Issued |
Array
(
[id] => 3601059
[patent_doc_number] => 05559250
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-24
[patent_title] => 'Treating red blood cell solutions with anti-viral agents'
[patent_app_type] => 1
[patent_app_number] => 8/464471
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20756
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/559/05559250.pdf
[firstpage_image] =>[orig_patent_app_number] => 464471
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464471 | Treating red blood cell solutions with anti-viral agents | Jun 4, 1995 | Issued |
Array
(
[id] => 3535891
[patent_doc_number] => 05556993
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-17
[patent_title] => 'Compounds for the photodecontamination of pathogens in blood'
[patent_app_type] => 1
[patent_app_number] => 8/465495
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 43
[patent_no_of_words] => 33692
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/556/05556993.pdf
[firstpage_image] =>[orig_patent_app_number] => 465495
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465495 | Compounds for the photodecontamination of pathogens in blood | Jun 4, 1995 | Issued |
Array
(
[id] => 3664565
[patent_doc_number] => 05625079
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Synthesizing psoralen compounds useful as intermediates'
[patent_app_type] => 1
[patent_app_number] => 8/462377
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 43
[patent_no_of_words] => 33757
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/625/05625079.pdf
[firstpage_image] =>[orig_patent_app_number] => 462377
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462377 | Synthesizing psoralen compounds useful as intermediates | Jun 4, 1995 | Issued |
Array
(
[id] => 3732942
[patent_doc_number] => 05665764
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Tricyclic inhibitors of matrix metalloproteinases'
[patent_app_type] => 1
[patent_app_number] => 8/460436
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9653
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665764.pdf
[firstpage_image] =>[orig_patent_app_number] => 460436
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460436 | Tricyclic inhibitors of matrix metalloproteinases | Jun 1, 1995 | Issued |
Array
(
[id] => 3828926
[patent_doc_number] => 05760074
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Treatment'
[patent_app_type] => 1
[patent_app_number] => 8/460151
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7343
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 448
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/760/05760074.pdf
[firstpage_image] =>[orig_patent_app_number] => 460151
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460151 | Treatment | Jun 1, 1995 | Issued |
| 08/458921 | INDANYLPIPERIDINES AS MELATONERGIC AGENTS | Jun 1, 1995 | Abandoned |
Array
(
[id] => 3590026
[patent_doc_number] => 05550259
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Clinical marker and therapeutic agent in kidney stone disease and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/460585
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6465
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/550/05550259.pdf
[firstpage_image] =>[orig_patent_app_number] => 460585
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460585 | Clinical marker and therapeutic agent in kidney stone disease and methods of use | Jun 1, 1995 | Issued |
Array
(
[id] => 3576950
[patent_doc_number] => 05523423
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-04
[patent_title] => 'Form of form 1 Ranitidine'
[patent_app_type] => 1
[patent_app_number] => 8/458253
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1919
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/523/05523423.pdf
[firstpage_image] =>[orig_patent_app_number] => 458253
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458253 | Form of form 1 Ranitidine | Jun 1, 1995 | Issued |
| 08/460819 | SUBSTITUTED ARYLALKYLAMINES AS NEUROKININ ANTAGONISTS | May 31, 1995 | Abandoned |
Array
(
[id] => 3591830
[patent_doc_number] => 05585503
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Compounds for the photodecontamination of pathogens in blood'
[patent_app_type] => 1
[patent_app_number] => 8/455053
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 23884
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585503.pdf
[firstpage_image] =>[orig_patent_app_number] => 455053
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455053 | Compounds for the photodecontamination of pathogens in blood | May 30, 1995 | Issued |